<DOC>
	<DOC>NCT03021811</DOC>
	<brief_summary>Multi-center, prospective, interventional, uncontrolled open-label study evaluating the real-life use of KLOX LumiHeal BioPhotonic System in chronic wounds management (venous leg ulcers, diabetic foot ulcers, pressure ulcers).</brief_summary>
	<brief_title>EUREKA Italy - Evaluation of Real-life Use of KLOX BioPhotonic System in Chronic Wounds Management</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<mesh_term>Leg Ulcer</mesh_term>
	<mesh_term>Pressure Ulcer</mesh_term>
	<mesh_term>Varicose Ulcer</mesh_term>
	<criteria>Signed and dated written informed consent form; Adult patient (at least 18 years old) having received a diagnosis of venous leg ulcer, diabetic foot ulcer or pressure ulcer by the Investigator; The treating physician (investigator) believes the KLOX LumiHeal BioPhotonic System would be an appropriate option; Both male and female patients must be willing to adhere to a medicallyaccepted birth control method during the course of the study; Willingness to comply with study requirements (visits, treatments, etc.). Female pregnant patient (by medical history or as ascertained by a pregnancy test); Breastfeeding female patient; Patients taking drugs/products (e.g., methotrexate, chemotherapy agents) or with conditions (e.g., porphyria) known to induce severe photosensitivity reactions; Patients with known skin hypersensitivity.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>